---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-001825"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:22:49.308327+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Praxis Precision Medicines prices $661M equity offering at $260/share, net proceeds ~$621M

## Summary
- Offering of 2,212,000 shares plus full exercise of underwriter option for 331,800 shares at $260/share.
- Net proceeds estimated at $621.2M after underwriting discounts and expenses.
- Underwriters: Piper Sandler, TD Securities, Guggenheim Securities; closing expected Jan 8, 2026.
- Proceeds to fund commercialization prep, R&D, and working capital; cash runway extended into 2028.
- Offering made under effective shelf registration (Form S-3 ASR filed Dec 23, 2024).

## SEC filing metadata
- accession: 0001104659-26-001825
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000110465926001825/0001104659-26-001825-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000110465926001825/tm261686d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-001825
- JSON: https://secwatch.observer/filing/0001104659-26-001825.json
- Plain text: https://secwatch.observer/filing/0001104659-26-001825.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.